FOREFRONT ANALYTICS, LLC Mereo BioPharma Group plc Transaction History

FOREFRONT ANALYTICS, LLC portfolio value:

$96,000
portfolio value

FOREFRONT ANALYTICS, LLC quarter portfolio value change:

-23.12%
quarter

Mereo BioPharma Group plc 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +48.71% 36.95K shares 13K $0.86 112.8K
Q2 2022 share Increase 0.00% 75.85K shares 83K $1.12 75.85K